Intriguingly, the presence of TERT promoter mutations represents a featured hallmark for aggressive TCs, as described earlier, whereas GABPA and GABPB1 expression is downregulated in those tumours.23, 25, 26. The gene discussed is GABPA; the disease is neoplasm.